02.27.07
Bristol-Myers Squibb Canada plans to consolidate its Clinical Supply Operations (CSO) and related functions located in Candiac into its recently expanded New Brunswick, NJ facility.
The CSO and related functions represent 75% of all Candiac site positions. The company's decision to close the Candiac facility affects approximately 115 employees. The company is offering opportunities to transfer to New Brunswick, NJ and other BMS sites in the U.S. Others will be offered severance and outplacement assistance.
The CSO and related functions represent 75% of all Candiac site positions. The company's decision to close the Candiac facility affects approximately 115 employees. The company is offering opportunities to transfer to New Brunswick, NJ and other BMS sites in the U.S. Others will be offered severance and outplacement assistance.